Ovid Therapeutics
Price & Volume
Stats
See moreOpen | $2.43 |
Previous Close | $2.43 |
Day Range | $2.37-$2.45 |
52W Range | $0.36-$3.10 |
Market Cap | $470.3M |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $7.1M |
Revenue Growth (YoY) | 844.7% |
Gross Profit (12 Mos) | $7.1M |
Diluted EPS | -$0.21 |
News
See moreYahoo Finance • 8 hours ago
Ovid Therapeutics (OVID) Appoints Kevin Norrett as Chief Business Officer
Yahoo Finance • 4 months ago
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
Yahoo Finance • 7 months ago
Promising Penny Stocks To Watch In December 2025
Yahoo Finance • 7 months ago
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
About
CEO | Ms. Margaret Alexander |
CFO | Mr. Charles Ross Carter M.B.A., M.S. |
Address | Hudson Commons, New York, NY, United States, 10001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |